These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 20044055

  • 1. Meningococcal conjugate vaccination among adolescents aged 13-17 years, United States, 2007.
    Lu PJ, Jain N, Cohn AC.
    Vaccine; 2010 Mar 08; 28(11):2350-5. PubMed ID: 20044055
    [Abstract] [Full Text] [Related]

  • 2. Vaccination coverage among adolescents aged 13-17 years - United States, 2007.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2008 Oct 10; 57(40):1100-3. PubMed ID: 18846032
    [Abstract] [Full Text] [Related]

  • 3. National vaccination coverage among adolescents aged 13-17 years--United States, 2006.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2007 Aug 31; 56(34):885-8. PubMed ID: 17728694
    [Abstract] [Full Text] [Related]

  • 4. Hepatitis B vaccination coverage among U.S. adolescents, National Immunization Survey-Teen, 2006.
    Jain N, Hennessey K.
    J Adolesc Health; 2009 Jun 31; 44(6):561-7. PubMed ID: 19465320
    [Abstract] [Full Text] [Related]

  • 5. Physician perspectives to inform a new recommendation for meningococcal conjugate vaccine (MCV4).
    Clark SJ, Cowan AE, Stokley S, Bilukha O, Davis MM.
    J Adolesc Health; 2006 Dec 31; 39(6):850-5. PubMed ID: 17116515
    [Abstract] [Full Text] [Related]

  • 6. National, state, and local area vaccination coverage among adolescents aged 13-17 years--United States, 2008.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2009 Sep 18; 58(36):997-1001. PubMed ID: 19763075
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Meningococcal Conjugate and Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccination Among HIV-infected Youth.
    Setse RW, Siberry GK, Moss WJ, Wheeling J, Bohannon BA, Dominguez KL, LEGACY Consortium.
    Pediatr Infect Dis J; 2016 May 18; 35(5):e152-7. PubMed ID: 26855409
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Timing of adolescent meningococcal conjugate vaccination attitudes and practices of pediatricians and family medicine physicians.
    Allison MA, Cohn AC, Stokley S, Crane LA, O'Leary ST, Hurley LP, Babbel CI, Dong F, Gahm C, Temte JL, Kempe A.
    Am J Prev Med; 2011 Dec 18; 41(6):581-7. PubMed ID: 22099234
    [Abstract] [Full Text] [Related]

  • 12. Phase III comparison of an investigational quadrivalent meningococcal conjugate vaccine with the licensed meningococcal ACWY conjugate vaccine in adolescents.
    Jackson LA, Baxter R, Reisinger K, Karsten A, Shah J, Bedell L, Dull PM, V59P13 Study Group.
    Clin Infect Dis; 2009 Jul 01; 49(1):e1-10. PubMed ID: 19476428
    [Abstract] [Full Text] [Related]

  • 13. Use of meningococcal vaccines in the United States.
    Bilukha O, Messonnier N, Fischer M.
    Pediatr Infect Dis J; 2007 May 01; 26(5):371-6. PubMed ID: 17468644
    [Abstract] [Full Text] [Related]

  • 14. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
    America Academy of Pediatrics Commitee on Infectious Diseases.
    Pediatrics; 2006 Mar 01; 117(3):965-78. PubMed ID: 16382131
    [Abstract] [Full Text] [Related]

  • 15. A comparison of parent and provider reported influenza vaccination status of adolescents.
    Lu PJ, Dorell C, Yankey D, Santibanez TA, Singleton JA.
    Vaccine; 2012 May 09; 30(22):3278-85. PubMed ID: 22445809
    [Abstract] [Full Text] [Related]

  • 16. Adolescent vaccination-coverage levels in the United States: 2006-2009.
    Stokley S, Cohn A, Dorell C, Hariri S, Yankey D, Messonnier N, Wortley PM.
    Pediatrics; 2011 Dec 09; 128(6):1078-86. PubMed ID: 22084326
    [Abstract] [Full Text] [Related]

  • 17. Report from the Advisory Committee on Immunization Practices (ACIP): decision not to recommend routine vaccination of all children aged 2-10 years with quadrivalent meningococcal conjugate vaccine (MCV4).
    Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2008 May 02; 57(17):462-5. PubMed ID: 18451758
    [Abstract] [Full Text] [Related]

  • 18. Prevention and control of meningococcal disease: recommendations for use of meningococcal vaccines in pediatric patients.
    American Academy of Pediatrics Committee on Infectious Diseases.
    Pediatrics; 2005 Aug 02; 116(2):496-505. PubMed ID: 15995007
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Invasive meningococcal disease epidemiology and control measures: a framework for evaluation.
    Caro JJ, Möller J, Getsios D, Coudeville L, El-Hadi W, Chevat C, Nguyen VH, Caro I.
    BMC Public Health; 2007 Jun 29; 7():130. PubMed ID: 17603880
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.